Home
/ Extrel
/ Competitors

Extrel Competitors and Similar CompaniesClear all

Extrel's competitors and similar companies include SCIEX, Wabtec and ESCO Technologies.

	Extrel Extrel is a manufacturer of research and process mass spectrometers, residual gas analyzers, and quadrupole mass spectrometry components.	SCIEX SCIEX is a company engaged in the field of mass spectrometry.	Wabtec Wabtec (also known as Westinghouse Air Brake Technologies) is a company that manufactures train control equipment and systems.	ESCO Technologies ESCO Technologies is a company that manufactures filtration and fluid control products.
Founding Date	Founding Date 1964	Founding Date 1970	Founding Date 1869	Founding Date 1990
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Public
Tags	Tags Manufacturing & Industrial electronic components electronics	Tags Manufacturing & Industrial clinical research medical devices medtech	Tags Manufacturing & Industrial electronic components electronics	Tags Manufacturing & Industrial electronic components mechanical components
Locations	Locations Pittsburgh, US HQ	Locations Framingham, US HQ Mount Waverley, AU Wien, AT São Paulo, BR Vaughan, CA Shanghai, CN Copenhagen, DK see more	Locations Pittsburgh, US HQ Greensburg, US Houston, US Wilmerding, US	Locations St. Louis, US HQ Stevenage, GB St. Louis, US
Employees	Employees 274% increase	Employees 2,6092% decrease	Employees 29,5002% increase	Employees 3,359
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 32.7 b	Valuation ($) 3.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $11.2b (FY, 2025)	Revenue (est.) $1.1b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $7.4b (FY, 2025)	Cost of goods $634.3m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $3.8b (FY, 2025)	Gross profit $461.1m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income $1.2b (FY, 2025)	Net income $299.2m (FY, 2025)
Operating ⚠
Backlog	Backlog N/A	Backlog N/A	Backlog $21.6b (FY, 2020)	Backlog $847.8m (Q1, 2024)
New Orders	New Orders N/A	New Orders N/A	New Orders $6.8b (FY, 2020)	New Orders $293.7m (Q1, 2024)